lyophilized powder comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-01-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.
Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.
Analytical characterization of epitalon relies on standard peptide methods. Reverse-phase high-performance liquid chromatography is used to assess purity, and mass spectrometry confirms identity by checking the observed mass against the expected value near 390 daltons. Amino acid analysis can verify composition. Because the peptide is short and hydrophilic, it elutes early on many reverse-phase columns, so method development often requires ion-pairing reagents to achieve adequate retention and resolution from related impurities.
The compound is generally described as a synthetic analogue of a fragment isolated from a pineal gland extract. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology introduced it during the 1980s and 1990s while studying short peptides from animal tissue. The original extract, called epithalamin, is a heterogeneous mixture, whereas epitalon is a single defined sequence. That distinction matters because findings reported for the extract are not automatically findings about the pure tetrapeptide, and claims about broader biological effects remain a separate question from the chemical identity described here.
Residue composition is the property that most cleanly separates verified material from mislabelled samples. Alanine, glutamate, aspartate and glycine appear in that order from the N-terminus, and the two acidic residues sit in the middle of the chain. Because the peptide is short, it can be produced by solid-phase synthesis and characterised by mass spectrometry without ambiguity. Any reported sample whose measured mass departs substantially from 390 daltons is a different compound or a degraded mixture rather than epitalon.
| Property | Value | Notes |
|---|---|---|
| Purity assessment | RP-HPLC | Reported as percent area, often ≥95% |
| Identity confirmation | Mass spectrometry | Observed mass compared with ~390 Da |
| Typical storage temperature | -20 °C or below | Lyophilized powder, desiccated |
| Reconstitution solvent | Sterile water or buffer | Acidic residues aid dissolution |
| Common synonyms | AEDG; epithalon | Spelling varies in literature |
The most frequently cited laboratory finding is that AEDG increased telomerase activity and extended telomere length in cultured human somatic cells. That work used fetal fibroblast strains and reported changes in enzyme activity alongside altered division counts. Replication by unrelated groups has been limited, and the published record is largely a single-laboratory series rather than a multi-centre programme. The result supports a hypothesis about peptide influence on gene expression in cell culture; it does not by itself establish an effect on telomere length in living animals or in people.
Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.
No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.
Epitalon is the common name for a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, usually abbreviated AEDG. All four residues are proteinogenic amino acids, and the free peptide has a calculated mass near 390 grams per mole. Because the chain is short and carries no modifications, it is assembled readily by solid-phase synthesis and is distributed mainly as a freeze-dried solid for laboratory work. Catalogue listings use the spellings epitalon, epithalone, and simply AEDG, and the three refer to the same sequence.
The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.
Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.
Identity and purity are checked by reversed-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, where the peptide bond absorbs. Mass spectrometry confirms the expected mass and reveals whether truncation products or adducts are present. Acid hydrolysis followed by amino acid analysis gives the residue ratio, which should approximate one alanine, one glutamate, one aspartate and one glycine. Counter-ions such as acetate or trifluoroacetate remain in the dried product and lower net peptide content, so a stated purity figure on a label does not by itself describe how much peptide a vial holds.
Regulatory treatment differs by country. No formulation of epitalon holds a marketing authorisation as a medicine in the United States or the European Union, where material sold for laboratory use is handled as a research chemical and is not intended for human consumption. In Russia, several short peptide preparations from the same institute's peptide series are registered medicinal products, and epitalon appears in that national context. Elsewhere it is frequently offered as a cosmetic ingredient, a category with lighter requirements. Advertising claims about longevity or disease prevention are restricted in most jurisdictions, which limits how sellers describe the compound.
Assassinian Jingi (アサシン星人ジンギ, Asashin Seijin Jingi): A self-centered scorpion-themed assassin from Planet Assassin who has a chain on his head capable of sending targets to another dimension and who considers his skills far beyond that of typical killers, becoming murderously violent whenever someone questions or insults him. He kills indiscriminately until the Dekarangers confront him. He pilots a Kaijuki called Ultimate Evil 2 (アルティメットイビル2, Arutimetto Ibiru Tsū) in retaliation, but is deleted by the Deka Wing Cannon. Jingi is voiced by Minami Takayama (高山 みなみ, Takayama Minami). Sumasuleenian Nikaradar (スマスリーナ星人ニカレーダ, Sumasurīna Seijin Nikarēda): A spiky squid-themed criminal, and breeder of alien monsters called Browgoul, from Planet Sumasuleen who is capable of disguising himself as others and is willing to sacrifice countless worlds to ensure his pets' existence. After arriving on Earth, he murdered a professor and fed his corpse to a hatched Browgoul before assuming the deceased's identity to redirect a meteor towards Earth. However, the Dekarangers discover his true identity and delete him via their S.W.A.T. Modes. Nikaradar is voiced by Hiroyuki Shibamoto (柴本 浩行, Shibamoto Hiroyuki). Bokudenian Biskes (ボクデン星人ビスケス, Bokuden Seijin Bisukesu): A reckless fish-themed criminal and former friend of Kruger's from Planet Bokuden who previously trained with him, is charged with illegally challenging 999 fighters in duels to the death, and possesses the Sword Altair (ソード・アルタイル, Sōdo Arutairu), with which he can perform the Altair Slash (アルタイルスラッシュ, Arutairu Surasshu) attack.
Venturing beyond Cumana, Humboldt and Bonpland received hospitality from local mulatto peasants, who were unfamiliar with their European origins but generous nonetheless. During one such excursion, they learned of a local laborer named Francisco Loyano, who had reportedly nursed a child with his own milk due to unusual lactation, a fact confirmed by local witnesses and Bonpland’s examination. By early September, acclimatized and prepared, Humboldt and Bonpland embarked on their first significant inland journey to the Cumanagoto tribe missions in the mountains south of Cumana. The challenging route led them through dense rainforest, across mountain streams, and along precipitous paths, where they marveled at the forest’s grandeur and the diversity of wildlife. The mission headquarters at Caripe, a cool, spring-fed location surrounded by mountains, became their base. Humboldt was surprised to find the Capuchin monks welcoming and tolerant, despite religious differences, and noted the presence of contemporary scientific texts among them. Daily life at Caripe was a blend of scientific work and cultural observation. Humboldt and Bonpland collected plants, studied the Cumanagoto language, and documented local customs, including the children’s consumption of large millipedes. Meals at the monastery reflected the monks’ sacrifices, as they often gave up their own rations for the guests. The soundscape was dominated by howler monkeys, especially during rain, and opportunities for astronomical observation were rare due to persistent mist.
== Mode of action == The exact activation mechanism of Ppk1/Ppk26 ion channels in the presence of Do6a is unknown; however, it likely compares to the mode of action of endogenous peptide Vulnusin due to their similarity in structure. Vulnusin binds to Ppk/Bba channels upon mechanical injury, yet administration of this peptide independently still results in channel activation and nociceptive rolling in Drosophila larvae. This could mean that a wound in larvae tissue allows Vulnusin, normally located above the epidermal layer, to reach its receptors below epidermal cells. Do6a, delivered to Ppk/Bba receptors through a mechanical puncture of the tissue from the velvet ant sting, could elicit its response through a similar mechanism. Since Ppk1/Ppk26 ion channels are homologous to Acid-sensing ion channels (ASICs) in vertebrates, they are likely to be permeable to cations, however, the exact ion type that passes through these channels upon activation has not been determined.
More recent advances in synthetic platelet technology have focused on biomimetic approaches to replicate the essential functions of native platelets known as adhesion, aggregation, and clot formation. Platelet-mimetic nanoparticles are designed to imitate platelet behavior without the systemic risks associated with transfusion. These constructs can self-assemble into structures that bind to tumor endothelial cells and transform into nanofibers, initiating artificial coagulation at targeted sites. This ability to localize coagulation without systemic effects is being further researched for applications in treating both bleeding disorders and cancer, where controlled clotting is necessary to achieve positive patient outcomes. Emerging solutions for blood transfusions also aim to address current limitations of donor platelet products. Recent research has focused on creating synthetic platelet analogs that enable engineered constructs to selectively bind to thrombus sites, potentially enhancing the precision of clotting therapies for conditions such as thrombosis. Furthermore, integrating these platelet-mimetic features into drug delivery vehicles offers the potential for targeted therapies in cardiovascular disease, anti-inflammation treatments, and immunotherapies. Addressing safety, enhancing production methods, and managing regulatory approvals are challenges that need to be resolved before synthetic platelets can enter human clinical trial development and be routinely used in practice.
Sources: en.wikipedia.org
=== 14 May === Russian missiles struck Ternopil Oblast, causing damage to civilian property. The Russian military claimed to have launched strikes on deployment points of Ukrainian forces and arms depots in the oblast as well as in Petropavlivka in Dnipropetrovsk Oblast. The Governor of Russia's Bryansk Oblast said a Ukrainian drone attack damaged a food processing facility in Starodub. The Russian Ministry of Defence confirmed the death of Colonels Vyacheslav Makarov and Yevgeny Brovko of the 4th Motorized Rifle Brigade during fighting in Bakhmut. The Russian military said it had repelled Ukrainian attacks in the north and south of Bakhmut while Yevgeny Prigozhin, head of the Wagner Group said his forces had advanced up to 130 metres (430 ft) over the past 24 hours. He also claimed control over 28 multi-story buildings in western districts of Bakhmut and estimated Ukrainian forces were still holding 20 buildings and a total area of 1.69 square km (0.65 square miles). Meanwhile, the Ukrainian Defence Ministry said its forces captured more than ten enemy positions in the north and south of Bakhmut and cleared a large area of forest near Ivanivske. The Washington Post, citing leaked documents from the Pentagon, reported that Prigozhin secretly contacted Ukrainian intelligence in January 2023 to reveal Russian military positions in exchange for a Ukrainian withdrawal from Bakhmut, which was refused, and advised them to advance towards Crimea while informing them of shortages in Russian ammunition.
== Risks == The risk of complications of the surgical wound is greater for those greater than 65-years-old, or who have pulmonary disease, nutritional deficiencies, overweight, other illnesses and high blood pressure.
=== Reunion: 2007–present === The Jesus and Mary Chain reunited to perform at Coachella on 27 April 2007. During "Just Like Honey", Scarlett Johansson, who starred in the film Lost in Translation featuring the song, performed with the band on the main stage. The band held a warm-up gig the day before in Pomona, California with Giant Drag's Annie Hardy as the guest. The band's first UK performance since reforming was at the Meltdown festival in June. In June 2007, Jim Reid revealed that the band was working on a new album. In March 2008, the band released "All Things Must Pass" for the soundtrack to NBC's television series Heroes, their first new song since 1998. In September 2008, Rhino Records released the 4-CD compilation The Power of Negative Thinking: B-Sides & Rarities. In 2010, a greatest hits album, Upside Down: The Best of The Jesus and Mary Chain, was released via Music Club Deluxe. The band toured North America in 2012 and also played China for the first time in May. The lineup featured guitarist John Moore and Fountains of Wayne drummer Brian Young replacing Loz Colbert. Mark Crozer replaced Moore beginning with the band's Tel Aviv shows in October. In 2013, it was announced that a full-discography vinyl box set, dubbed as The Complete Vinyl Collection, would be released for the band's 30th anniversary, via Demon Music Group. In 2014, the band became the first to sign to the newly reformed Creation Management, helmed by Alan McGee. The band played Psychocandy in full through 2015 to celebrate the album's 30th anniversary.
Sources: en.wikipedia.org
Identity is normally confirmed by mass spectrometry, which checks the measured mass against the expected value near 390 daltons. Reverse-phase high-performance liquid chromatography is used alongside it to assess purity. Amino acid analysis can provide additional composition data.
The powder is generally kept refrigerated or frozen, protected from light and moisture. Vials should reach room temperature before opening to prevent condensation. Reconstituted solutions are usually stored cold and used within a limited window because dilute solutions can degrade or support microbial growth.
Epitalon is not an approved drug in major Western regulatory jurisdictions. Its legal status differs between countries, and it is often distributed as a research chemical. This means product documentation and purity vary considerably between suppliers.
It is a four-amino-acid peptide built from alanine, glutamate, aspartate and glycine in that order. Its formula is C14H22N4O9, and it is made by chemical synthesis rather than extracted from tissue. The synthetic peptide is a single defined molecule, unlike the pineal extracts it is often compared with.